fincash logo SOLUTIONS
EXPLORE FUNDS
CALCULATORS
LOG IN
SIGN UP

Fincash » Search » Suven Life Sciences Ltd

Suven Life Sciences Ltd

Updated on October 15, 2020

Stock/Share Code - SUVEN

Suven Life Sciences is engaged in providing building blocks (bulk actives, drug intermediates and speciality chemicals) for global life science companies.

Below is the details of SUVEN Suven Life Sciences Ltd

Market Cap₹631.32 Cr.
Current Price ₹48.05 as on 21 Oct 20
52 Week High / Low Price₹67.5 / ₹15.2
Face Value₹1
Stock P/E
Book Value₹30.45
Dividend Yield3.02 %
ROCE-6.49 %
ROE-3.61 %
Sales Growth (3yrs)-71.47 %
SectorPharmaceuticals
IndustryPharmaceuticals - Indian - Bulk Drugs
Listed onBSE  AND  NSE
Company WebsiteCompany Website
Pros: Company is virtually debt free. Company has been maintaining a healthy dividend payout of 20.26%
Cons: Company has low interest coverage ratio. The company has delivered a poor growth of -52.48% over past five years. Company has a low return on equity of 8.65% for last 3 years. Debtor days have increased from 34.98 to 65.65 days.

Suven Life Sciences Ltd Price Chart

Suven Life Sciences Ltd Price Chart

Suven Life Sciences Ltd Peer Comparison in Pharmaceuticals

S.No. Name CMP Rs. P/E Mar Cap Rs.Cr. Div Yld % NP Qtr Rs.Cr. Qtr Profit Var % Qtr Sales Var % Sales Qtr Rs.Cr. ROCE %
1. Divi's Lab. ₹141 51.94 ₹82,900.53 Cr. 0.51 ₹492.06 Cr. 80.61 48.81 1730.47 25.19
2. Lupin ₹1,002.55 ₹42,032.3 Cr. 0.65 ₹106.9 Cr. -64.73 -9.02 3527.86 9.23
3. Jubilant Life ₹706.05 13.50 ₹12,477.17 Cr. 0.64 ₹260.49 Cr. 248.25 0.24 2391.41 15.46
4. Granules India ₹386.35 22.60 ₹7,765.53 Cr. 0.32 ₹111.45 Cr. 33.89 23.57 735.60 17.15
5. Aarti Drugs ₹769.1 31.46 ₹6,319.31 Cr. 0.07 ₹85.45 Cr. 280.62 34.34 544.67 20.87
6. Shilpa Medicare ₹469.25 23.66 ₹4,289.13 Cr. 0.21 ₹86.31 Cr. 159.66 38.43 222.86 12.62
7. Sequent Scien. ₹154.25 40.58 ₹3,221.37 Cr. 0.15 ₹20.92 Cr. 82.55 11.60 310.27 12.29
8. Suven Life Scie. ₹631.32 Cr. 3.02 -₹4.08 Cr. -189.87 -10.06 1.43 -6.49

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Suven Life Sciences Ltd Fundamentals

Quarterly Results

Quarterly reports are issued by companies every three months. Most companies have a financial year-end of Mar. 31 and quarters that end on June 30, Sept. 30, Dec. 31 and March 31.

Standalone Figures in Rs. Crores

Sep 2017Dec 2017Mar 2018Jun 2018Sep 2018Dec 2018Mar 2019Jun 2019Sep 2019Dec 2019Mar 2020Jun 2020
Sales -106.86163.66213.72191.6689.522.112.381.591.392.778.661.43
YOY Sales Growth %-7.52%41.64%18.63%35.91%-16.23%-98.71%-98.89%-99.17%-98.45%31.28%263.87%-10.06%
Expenses -61.86112.27122.49133.4365.1115.7920.5312.9013.9012.1310.749.22
Material Cost %10%30%28%34%6%0%0%0%0%0%0%0%
Employee Cost %12%9%7%9%16%299%89%282%302%87%40%238%
Operating Profit45.0051.3991.2358.2324.41-13.68-18.15-11.31-12.51-9.36-2.08-7.79
OPM %42.11%31.40%42.69%30.38%27.27%-648.34%-762.61%-711.32%-900.00%-337.91%-24.02%-544.76%
Other Income5.133.299.238.136.596.745.792.802.385.863.002.53
Interest0.941.151.251.070.590.000.290.110.100.100.230.22
Depreciation5.345.425.365.515.560.990.800.851.420.861.051.06
Profit before tax43.8548.1193.8559.7824.85-7.93-13.45-9.47-11.65-4.46-0.36-6.54
Tax %27.59%28.10%33.39%35.03%27.53%-4.92%30.33%147.94%3.52%-0.90%-611.11%37.77%
Net Profit31.7534.6062.5138.8418.01-8.32-9.384.54-11.23-4.50-2.56-4.08
EPS in Rs2.492.724.913.051.41-0.65-0.740.36-0.88-0.35-0.20-0.32
NotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotesNotes

Profit & Loss

The profit and loss (P&L) statement is a financial statement that summarizes the revenues, costs and expenses incurred during a specified period, usually a fiscal quarter or year. The P&L statement is synonymous with the income statement. These records provide information about a company's ability or inability to generate profit" by increasing revenue, reducing costs or both. Some refer to the P&L statement as a statement of profit and loss, income statement, statement of operations, statement of financial results or income, earnings statement or expense statement.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020TTM
Sales -1401291502042585105214995436252861314
Sales Growth %19%-8%16%36%26%98%2%-4%9%15%-54%-96%
Expenses -1221161371812052913613693783922374846
Material Cost %35%30%37%37%32%27%35%33%28%25%25%0%
Manufacturing Cost %13%13%14%14%15%11%12%15%15%14%17%13%
Employee Cost %12%12%12%11%10%6%7%8%9%9%12%116%
Other Cost %28%35%28%27%22%14%15%17%17%15%29%251%
Operating Profit171314235321915913016523349-35-32
OPM %12%10%9%11%21%43%31%26%30%37%17%-279%-223%
Other Income-1012139192123271414
Interest7561014115665211
Depreciation555689121821211144
Profit before tax54393320315212615923063-26-23
Tax %-40%-89%-219%-57%6%29%28%20%23%31%38%47%
Net Profit7710143114410910012315839-14-22
EPS in Rs0.570.560.851.182.6412.348.547.869.7012.453.080.00-1.75
Dividend Payout %41%41%28%24%11%20%7%25%10%12%49%0%

Compounded Sales Growth

  • 10 Years:: -20.75%
  • 5 Years:: -52.48%
  • 3 Years:: -71.47%
  • TTM:: -85.09%

Compounded Profit Growth

  • TTM:: -561.24%

Return on Equity

  • 10 Years:: 37.88%
  • 5 Years:: 26.98%
  • 3 Years:: 63.69%
  • 1 Year:: 177.06%

Balance Sheet

A balance sheet is a financial statement that reports a company's assets, liabilities and shareholders' equity at a specific point in time, and provides a basis for computing rates of return and evaluating its capital structure. It is a financial statement that provides a snapshot of what a company owns and owes, as well as the amount invested by shareholders. It is used alongside other important financial statements such as the income statement and statement of cash flows in conducting fundamental analysis or calculating financial ratios.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Share Capital -121212121212131313131313
Equity Capital11.5911.5911.6711.6711.6811.6812.7312.7312.7312.7312.7312.73
Reserves103106115116143253547611719854389375
Borrowings435066981179110983713436
Other Liabilities -293731605613210568741143516
Trade Payables20.1826.0818.9225.1136.1440.9043.8935.6037.9456.827.095.78
Advance from Customers1.163.040.158.380.880.000.004.837.658.240.030.01
Other liability items7.257.5112.0726.1719.0790.7261.4127.3228.2648.7327.9210.28
Total Liabilities1862052242853284877737748761,014439410
Fixed Assets -1121101061321621791723053063082225
Gross Block150.79155.79159.77198.89238.30267.40290.52325.15348.91375.6839.4843.62
Accumulated Depreciation38.5346.2354.0966.4576.7988.17118.5719.8043.1967.9517.1318.92
CWIP433244131077102500
Investments61220500023366381359242
Other Assets -64809412416229549443819530158143
Inventories27303346547982839313900
Trade receivables2133312524654054466232
Cash Equivalents1233226828024152101
Loans n Advances393948687971789394955650
Other asset items-25-24-21-19-171214-33-42-16-190
Total Assets1862052242853284877737748761,014439410

Cash Flows

Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business. At the most fundamental level, a company’s ability to create value for shareholders is determined by its ability to generate positive cash flows, or more specifically, maximize long-term free cash flow.

Standalone Figures in Rs. Crores

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
Cash from Operating Activity -3413534311211439014710576
Profit from operations2516173055219172137172241230-8
Receivables11-8-40-15-4925-138-16-890
Inventory-3-3-3-12-7-25-3-2-9-47-180
Payables29-5174163-82194-1
Loans Advances000000-500000
Other WC items000000-1239-48-5-92
Working capital changes11-3-115-19-578-2010-92-107-93
Direct taxes-1-0-0-2-6-41-38-27-35-44-47-3
Cash from Investing Activity --15-10-12-32-15-36-110-62-353-38-62
Fixed assets purchased-12-5-4-27-20-38-118-58-31-42-98-2
Fixed assets sold000000000000
Investments purchased-4-5-9-5000-23-343-37-34-105
Investments sold000040016204070222
Interest received00000122110-13
Dividends received000111600000
Other investing items000-0-0-0-000-0-00
Cash from Financing Activity --21-28-23-38179-68-30-52-23
Proceeds from shares0.340.001.690.000.200.00200.000.000.000.000.000.00
Proceeds from borrowings0.006.9515.6911.390.000.0018.26-4.076.320.094.723.98
Repayment of borrowings-11.500.000.000.000.000.00-0.32-17.76-15.71-24.55-0.45-0.69
Interest paid fin-6.25-5.44-6.10-9.83-12.84-7.63-4.64-5.87-5.67-4.61-3.76-0.54
Dividends paid-3.38-3.39-3.40-3.39-4.07-4.10-34.17-39.83-12.73-22.98-23.020.00
Other financing items0.000.000.000.0019.26-26.500.00-0.52-2.590.000.000.00
Net Cash Flow-211-01947212-40-23615-8

Ready to Invest?
Talk to our investment specialist
Disclaimer:
By submitting this form I authorize Fincash.com to call/SMS/email me about its products and I accept the terms of Privacy Policy and Terms & Conditions.

Ratios

Mar 2009Mar 2010Mar 2011Mar 2012Mar 2013Mar 2014Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020
ROCE %11%5%5%9%19%68%31%17%19%25%7%-6%
Debtor Days56927645344728393136366
Inventory Turnover2.221.632.062.252.092.452.602.372.081.631.29

Announcements & News

Recent Announcements

How to Invest in Mutual Funds SIP Online?

  1. Open Free Investment Account for Lifetime at Fincash.com.
  2. Complete your Registration and KYC Process
  3. Upload Documents (PAN, Aadhaar, etc.). And, You are Ready to Invest! Get Started
  4. Invest in Mutual Funds which invests in Suven Life Sciences Ltd & Get More Returns than Bank Deposit

Disclaimer:
All efforts have been made to ensure the information provided here is accurate as per time to time filling by company to exchanges. However, no guarantees are made regarding correctness of data. Investors are advised to validate/check information with exchanges or companies website before making any investment decisions.